report cover1

Global Prostate Cancer Therapeutics Market: By Therapy: Hormonal therapy (Luteinizing Hormone-Releasing-Hormone Antagonists, Hormone-Releasing-Hormone Agonists & Anti-Androgens), Chemotherapy (Taxotere and Jevtana), Biologics Therapy (Provenge and Others), Targeted Therapy (Xofigo and Others), (By End- User: Hospitals, Specialized Clinics, Ambulatory Surgical Centers and Others), (By Region: North America, Europe, Asia Pacific, Latin America, and Middle East and Africa), Market Outlook: Drivers, restraints, opportunities and challenges, Segment analysis, key market players, Report overview, Competitive Landscape, Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2030

A prominent research firm, Cognizance Market Research added a cutting-edge industry report on the “Global Prostate Cancer Therapeutics Market”. The report studies the current as well as past growth trends and opportunities for the market to gain valuable insights during the forecast period from 2022 to 2030.

Global Prostate Cancer Therapeutics Market Analysis

According to cognizance market research, the Global Prostate Cancer Therapeutics Market was valued at US$ 12,798.4 Million in 2022 and is anticipated to reach US$ 23,231.4 Million by the end of 2030 with a CAGR of 7.8% from 2023 to 2030.

prostate cancer therapeutics market

What are Prostate Cancer Therapeutics?

Prostate cancer is a widespread form of cancer that affects the prostate gland, mainly impacting older individuals and those with sedentary lifestyles. This disease has gained prominence due to factors like an aging population and lifestyle habits in industrialized countries. The focus on improving patient-centered care through research is expected to drive innovation and lead to more effective treatments. However, factors such as health insurance coverage and payment options could also shape the landscape of prostate cancer care.

Over the past decade, significant advancements have been made in treating prostate cancer. Medications such as enzalutamide, abiraterone acetate, silence-T, cabazitaxel, and radium-233 have played a vital role in enhancing treatment outcomes. Patients often prefer treatments with fewer side effects, like androgen-independent therapies, which could lead to increased production by companies in the industry.

Prostate cancer occurs when abnormal cells in the prostate gland grow uncontrollably. It ranks as the sixth leading cause of death among men and the tenth overall. Treatment options include surgery, hormone therapy, radiation, chemotherapy, and biological therapy. Diagnostic and procedural approaches range from specific types of prostate cancer to non-cancerous conditions.

Out of all types of cancer, prostate cancer significantly affects men, causing a substantial number of male deaths and ranking eleventh overall. The demand for new drugs in the prostate cancer market arises from the need for treatments that offer longer survival, reduced side effects, improved efficacy, and affordability. The market focuses on 21 key drugs across various categories, with 13 drugs currently available and 8 more in development.

Prostate cancer rates have increased by 25% in developed countries and 40% in developing nations. This growth is driven by the factors mentioned earlier, along with the expected launch of new medications and a growing elderly male population. Hormonal therapies play a pivotal role in treating prostate cancer through different methods. Next-generation hormonal therapy has particularly impacted treatment approaches for specific stages of the disease, often involving combinations of advanced therapies.

Global Prostate Cancer Therapeutics Market Outlook

The rising prevalence of prostate cancer serves as the primary catalyst propelling the expansion of the market. The landscape of prostate cancer therapeutics is significantly influenced by the escalating healthcare costs. Nevertheless, there is a simultaneous increase in government funding and initiatives from both private and public organizations to raise awareness. This concerted effort is expected to foster growth in the prostate cancer treatment market. Additional factors contributing to this growth include advancements in screening and diagnostic technologies, coupled with evolving lifestyle patterns. However, the market growth could be tempered by the aging population, developments in genetics and proteomics and the associated challenges they present. On the other hand, the availability of robust new pharmaceuticals and a robust pipeline are poised to accelerate the expansion of the prostate cancer treatment market. The market also stands to benefit from heightened research and development efforts and the introduction of novel drugs throughout the anticipated period from 2022 to 2030. The substantial unmet needs and increased pharmaceutical expenditure in developing nations are anticipated to sustain the growth of the prostate cancer treatment marketplace. While the market is projected to grow, factors such as high treatment costs and a history of underperforming anticancer drugs in clinical trials may curtail its potential. Negative side effects associated with these medications could further impede the growth of the prostate cancer therapy market. Challenges are anticipated to persist due to reduced awareness and prolonged treatment durations during the projected period.

The global pandemic has wielded a significant impact on various facets of cancer care, including physician-patient relationships, therapy accessibility, and treatment decisions. Alongside numerous economic, social, and health-related consequences that have intensified existing vulnerabilities, such as those linked to pollution, the pandemic has also significantly affected various other health concerns. Consequently, cancer mortality rates have experienced a gradual decline. Notably, COVID-19 has been correlated with elevated mortality rates in cancer patients when compared to non-cancer individuals.

Key players in the market are focused on developing novel and cutting-edge products. Over the projected timeframe, numerous companies are expected to introduce products to the market. For instance, a study involving a combination of Keytruda and Lynparza for metastatic castration-resistant prostate cancer was conducted in March 2022. Government support for innovative prostate cancer treatments is propelling market expansion. An example is the authorization of 177Lu-PSMA-617 by the US FDA in March 2022. This groundbreaking treatment, developed by the Society of Nuclear Medicine and Molecular Imaging, has shown a 38% reduction in mortality risk. This innovative therapy leverages PET scans for diagnosing and treating patients with prostate cancer expressing PSMA (prostate-specific membrane antigen).

However, targeted therapy remains inaccessible to the general population due to its elevated cost. For instance, the American Society of Clinical Oncology has highlighted that the cost of cancer medications in the US is notably higher, ranging from two to six times more expensive compared to the rest of the world, and more than twice as expensive as in Europe.

Segment Analysis:

The global market for prostate cancer therapeutics is segmented based on therapy and end users. The therapy categories within the market include hormonal therapy, chemotherapy, biological therapy, and targeted therapy.

Under hormonal therapy, there are subcategories including Luteinizing Hormone-Releasing Hormone (LHRH) Antagonists, Hormone-Releasing Hormone (LHRH) Agonists, and Anti-Androgens. The chemotherapy segment is divided into Taxotere and Jevtana. Targeted therapy encompasses Xofigo and Other targeted therapies. The biologic therapy category includes Provenge and other biologic therapies. The hormone therapy segment led the market in 2022 and is projected to maintain this trend throughout the forecast period. Given its ability to reduce cancer recurrence risk and slow its growth, the hormone therapy market is expected to experience rapid expansion during the forecast period. Notably, new antiandrogens and luteinizing hormone-releasing hormone antagonists like Zytiga and Xtandi are being introduced, which is poised to accelerate growth in the hormone therapy market. Prostate cancer ranks as the second most frequent cancer in men and the fourth most common overall, according to the World Health Organization.

The end-user segments encompass hospitals, specialized clinics, ambulatory surgical centers, and others. Based on end-users, the global market for prostate cancer therapies is further categorized into hospital pharmacies, retail pharmacies, and online sales. The hospital pharmacies segment is anticipated to dominate the market during the forecast period. This dominance is attributed to the significant portion of prostate cancer treatments conducted in hospitals, along with their streamlined reimbursement processes. The hospital pharmacies segment is closely linked to hospital treatments and benefits from mechanisms like the Simple Reimbursement Procedure to Enhance Hospital Pharmacies Segment. The presence of major corporations in the field has contributed to an expansion in the range of therapies offered within this segment.

Geographical Analysis:

Geographically, the Global Prostate Cancer Therapeutics Market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

North America held a significant share of nearly 50% of the global prostate cancer treatment market in 2022, and this dominance is expected to persist throughout the forecast period. The reasons behind this include the increased utilization of prostate cancer treatment products, widespread availability of therapeutic medications, the substantial presence of pharmaceutical companies, and a well-developed healthcare infrastructure.

Conversely, the Asia-Pacific region is projected to witness the highest growth rate during the forecast period. This growth can be attributed to improvements in healthcare infrastructure, an increasing number of hospitals equipped with advanced medical technologies, a thriving research and development sector, and technological advancements in the region.

Europe emerged as the second-largest market for prostate cancer therapeutics in 2022, largely driven by the high prevalence of the disease and heightened public awareness. The hormone treatment market in Europe experienced growth, with drugs like Zytiga and Xtandi contributing to increased sales. The broader European prostate cancer treatment market is expected to expand due to significant unmet clinical needs and an aging male population.

The Global Prostate Cancer Therapeutics Market demonstrates varying trends across different geographical regions, with North America maintaining its dominant position, Asia-Pacific showing substantial growth potential, and Europe driven by disease prevalence and awareness.

geographical analysis

The report offers the revenue of the global prostate cancer therapeutics market for the period 2022-2030, considering 2020 & 2021 as historical years, 2022 as the base year, and 2023 to 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global prostate cancer therapeutics market for the forecast period. The global prostate cancer therapeutics market report provides insights and in-depth analysis into developments impacting enterprises and businesses on a regional and global level. The report covers the global prostate cancer therapeutics market performance in terms of revenue contribution from several segments and comprises a detailed analysis of key drivers, trends, restraints, and opportunities prompting revenue growth of the global prostate cancer therapeutics market.

The report has been prepared after wide-ranging secondary and primary research. Secondary research included internet sources, numerical data from government organizations, trade associations, and websites. Analysts have also employed an amalgamation of bottom-up and top-down approaches to study numerous phenomena in the global prostate cancer therapeutics market. Secondary research involved a detailed analysis of significant players’ product portfolios. Literature reviews, press releases, annual reports, white papers, and relevant documents have been also studied to understand the global prostate cancer therapeutics market. Primary research involved a great extent of research efforts, wherein experts carried out interviews telephonic as well as questioner-based with industry experts and opinion-makers.

The report includes an executive summary, along with a growth pattern of different segments included in the scope of the study. The Y-o-Y analysis with elaborate market insights has been provided in the report to comprehend the Y-o-Y trends in the Global Prostate Cancer Therapeutics Market. Additionally, the report focuses on altering competitive dynamics in the global market. These indices serve as valued tools for present market players as well as for companies interested in participating in the global prostate cancer therapeutics market. The subsequent section of the global prostate cancer therapeutics market report highlights the USPs, which include key industry events (product launch, research partnership, acquisition, etc.), technology advancements, pipeline analysis, prevalence data, and regulatory scenarios.

Global Prostate Cancer Therapeutics Market Competitive Landscape

The “Global Prostate Cancer Therapeutics Market study report will provide valuable insight with an emphasis on the global market including some of the major players such as:

  • Sanofi
  • Astellas Pharma US, Inc.
  • Myovant Sciences Ltd.
  • Ipsen Pharma
  • AbbVie Inc.
  • Johnson & Johnson Services, Inc.
  • BG Bayer
  • AstraZeneca
  • Tolmar Pharmaceuticals Inc.
  • Ferring B.V
  • Takeda Pharmaceutical company
  • Teva Pharmaceutical Industries Ltd.
  • Dendreon Pharmaceuticals LLC
  • Pfizer Inc.
  • Abbott
  • GlaxoSmithKline plc
  • Bristol-Myers Squibb Company
  • Hoffmann-La Roche Ltd
  • Novartis AG
  • Genentech, Inc

In 2022, Pfizer, Inc. held the second-largest share of the world market for prostate cancer treatments. When it comes to the supply of medicinal items for prostate cancer, it is anticipated to rule the world market. In 2022, Janssen Biotech (Johnson & Johnson) held the third-largest market share for prostate cancer treatments worldwide. The main brand used to treat prostate cancer was Zytiga.

The report explores the competitive scenario of the Global Prostate Cancer Therapeutics Market. Major players operating in the Global Prostate Cancer Therapeutics Market have been identified and profiled for unique commercial attributes. Company overview (company description, product portfolio, geographic presence, employee strength, Key management, etc.), financials, SWOT analysis, recent developments, and key strategies are some of the features of companies profiled in the Global Prostate Cancer Therapeutics Market report.


Global Prostate Cancer Therapeutics Market, by Therapy

  • Hormonal Therapy
    • Luteinizing Hormone-Releasing Hormone Antagonists
    • Hormone-Releasing-Hormone Agonists
    • Anti-Androgen
  • Chemo Therapy
    • Taxotere
    • Jevtana
  • Biologics Therapy
    • Provenge
    • Others
  • Targeted Therapy
    • Xofigo
    • Others

Global Prostate Cancer Therapeutics Market, by End-user

  • Hospitals
  • Specialized Clinics
  • Ambulatory Surgical Centres
  • Others

Global Prostate Cancer Therapeutics Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia & New Zealand
    • South Korea
    • Rest Of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest Of Middle East & Africa
Complete the form below and we'll get back to you shortly
Table of Content

Research Methodology: Aspects

Market research is a crucial tool for organizations aiming to navigate the dynamic landscape of customer preferences, business trends, and competitive landscapes. At Cognizance Market Research, acknowledging the importance of robust research methodologies is vital to delivering actionable insights to our clientele. The significance of such methodologies lies in their capability to offer clarity in complexity, guiding strategic management with realistic evidence rather than speculation. Our clientele seek insights that excel superficial observations, reaching deep into the details of consumer behaviours, market dynamics, and evolving opportunities. These insights serve as the basis upon which businesses craft tailored approaches, optimize product offerings, and gain a competitive edge in an ever-growing marketplace.

The frequency of information updates is a cornerstone of our commitment to providing timely, relevant, and accurate insights. Cognizance Market Research adheres to a rigorous schedule of data collection, analysis, and distribution to ensure that our reports reflect the most current market realities. This proactive approach enables our clients to stay ahead of the curve, capitalize on emerging trends, and mitigate risks associated with outdated information.

Our research process is characterized by meticulous attention to detail and methodological rigor. It begins with a comprehensive understanding of client objectives, industry dynamics, and research scope. Leveraging a combination of primary and secondary research methodologies, we gather data from diverse sources including surveys, interviews, industry reports, and proprietary databases. Rigorous data analysis techniques are then employed to derive meaningful insights, identify patterns, and uncover actionable recommendations. Throughout the process, we remain vigilant in upholding the highest standards of data integrity, ensuring that our findings are robust, reliable, and actionable.

Key phases involved in in our research process are mentioned below:


Understanding Clients’ Objectives:

Extensive Discussions and Consultations:

  • We initiate in-depth discussions and consultations with our clients to gain a comprehensive understanding of their objectives. This involves actively listening to their needs, concerns, and aspirations regarding the research project.
  • Through these interactions, we aim to uncover the underlying motivations driving their research requirements and the specific outcomes they hope to achieve.

Industry and Market Segment Analysis:

  • We invest time and effort in comprehensively understanding our clients’ industry and market segment. This involves conducting thorough research into market trends, competitive dynamics, regulatory frameworks, and emerging opportunities or threats.
  • By acquiring a deep understanding of the broader industry landscape, we can provide context-rich insights that resonate with our clients’ strategic objectives.

Target Audience Understanding:

  • We analyze our clients’ target audience demographics, behaviors, preferences, and needs to align our research efforts with their consumer-centric objectives. This entails segmenting the audience based on various criteria such as age, gender, income level, geographic location, and psychographic factors.
  • By understanding the nuances of the target audience, we can tailor our research methodologies to gather relevant data that illuminates consumer perceptions, attitudes, and purchase intent.


Identifying Challenges and Opportunities:

  • We proactively identify the challenges and opportunities facing our clients within their respective industries. This involves conducting SWOT (Strengths, Weaknesses, Opportunities, Threats) analyses and competitive benchmarking exercises.
  • By identifying potential obstacles and growth drivers, we can provide strategic recommendations that help our clients navigate complexities and capitalize on emerging opportunities effectively.

Grasping Specific Goals:

  • We delve into the intricacies of our clients’ objectives to gain clarity on the specific goals they aim to accomplish through the research. This entails understanding their desired outcomes, such as market expansion, product development, or competitive analysis.
  • By gaining a nuanced understanding of our clients’ goals, we can tailor our research approach to address their unique challenges and opportunities effectively.

Data Collection:


Primary Research Process:

  • Surveys: We design and administer surveys tailored to capture specific information relevant to our clients’ objectives. This may involve employing various survey methodologies, such as online, telephone, or face-to-face interviews, to reach target audiences effectively.
  • Interviews: We conduct structured or semi-structured interviews with key stakeholders, industry experts, or target consumers to gather in-depth insights and perspectives on relevant topics. These interviews allow us to probe deeper into specific issues and uncover valuable qualitative data.
  • Focus Groups: We organize focus group discussions with carefully selected participants to facilitate interactive discussions and gather collective opinions, attitudes, and preferences. This qualitative research method provides rich contextual insights into consumer behaviors and perceptions.
  • Observations: We conduct observational research by directly observing consumer behaviors, interactions, and experiences in real-world settings. This method enables us to gather objective data on consumer actions and reactions without relying on self-reported information.

Secondary Research Process:

  • Literature Review: We conduct comprehensive literature reviews to identify existing studies, academic articles, and industry reports relevant to the research topic. This helps us gain insights into previous research findings, theoretical frameworks, and best practices.
  • Industry Reports: We analyze industry reports published by reputable trade associations (whitepapers, research studies, etc.), and government agencies (U.S. Census Bureau, Bureau of Labor Statistics, and Securities and Exchange Commission etc.) to obtain macro-level insights into market trends, competitive landscapes, and industry dynamics.
  • Government Publications: We review government publications, such as economic reports, regulatory documents, and statistical databases, to gather relevant data on demographics, market size, consumer spending patterns, and regulatory frameworks.
  • Online Databases: We leverage online databases, such as industry portals, and academic repositories (PubMed Central (PMC), ScienceDirect, SSRN (Social Science Research Network), Directory of Open Access Journals (DOAJ), NCBI, etc.), to access a wide range of secondary data sources, including market statistics, financial data, and industry analyses.





Data Analysis:

The data analysis phase serves as a critical juncture where raw data is transformed into actionable insights that inform strategic decision-making. Through the utilization of analytical methods such as statistical analysis and qualitative techniques like thematic coding, we uncover patterns, correlations, and trends within the data. By ensuring the integrity and validity of our findings, we strive to provide clients with accurate and reliable insights that accurately reflect the realities of the market landscape.



Transformation of Raw Data:

  • Upon collecting the necessary data, we transition into the data analysis phase, where raw data is processed and transformed into actionable insights. This involves organizing, cleaning, and structuring the data to prepare it for analysis.

Utilization of Analytical Methods:

  • Depending on the research objectives, we employ a diverse range of analytical methods to extract meaningful insights from the data. These methods include statistical analysis, trend analysis, regression analysis, and qualitative coding.

Statistical Analysis:

  • Statistical tools are instrumental in uncovering patterns, correlations, and trends within the data. By applying statistical techniques such as descriptive statistics, hypothesis testing, and multivariate analysis, we can discern relationships and derive valuable insights.

Qualitative Analysis Techniques:

  • In addition to quantitative analysis, we leverage qualitative analysis techniques to gain deeper insights from qualitative data sources such as interviews or open-ended survey responses. One such technique is thematic coding, which involves systematically categorizing and interpreting themes or patterns within qualitative data.

Integrity and Validity Maintenance:

  • Throughout the analysis process, we maintain a steadfast commitment to upholding the integrity and validity of our findings. This entails rigorous adherence to established methodologies, transparency in data handling, and thorough validation of analytical outcomes.

Data Validation:

The final phase of our research methodology is data validation, which is essential for ensuring the reliability and credibility of our findings. Validation involves scrutinizing the collected data to identify any inconsistencies, errors, or biases that may have crept in during the research process. We employ various validation techniques, including cross-referencing data from multiple sources, conducting validity checks on survey instruments, and seeking feedback from independent experts or peer reviewers. Additionally, we leverage internal quality assurance protocols to verify the accuracy and integrity of our analysis. By subjecting our findings to rigorous validation procedures, we instill confidence in our clients that the insights they receive are robust, reliable, and trustworthy.


Importance of Data Validation:

  • Data validation is the final phase of the research methodology, crucial for ensuring the reliability and credibility of the findings. It involves a systematic process of reviewing and verifying the collected data to detect any inconsistencies, errors, or biases.

Scrutiny of Collected Data:

  • The validation process begins with a thorough scrutiny of the collected data to identify any discrepancies or anomalies. This entails comparing data points, checking for outliers, and verifying the accuracy of data entries against the original sources.

Validation Techniques:

  • Various validation techniques are employed to ensure the accuracy and integrity of the data. These include cross-referencing data from multiple sources to corroborate findings, conducting validity checks on survey instruments to assess the reliability of responses, and seeking feedback from independent experts or peer reviewers to validate the interpretation of results.

Internal Quality Assurance Protocols:

  • In addition to external validation measures, internal quality assurance protocols are implemented to further validate the accuracy of the analysis. This may involve conducting internal audits, peer reviews, or data validation checks to ensure that the research process adheres to established standards and guidelines.

Report Scope:



Market Size

US$ 23,231.4 Million (2030)

Compound Annual Growth Rate (CAGR)


Base Year


Forecast Period


Forecast Units

Value (US$ Million)

Report Coverage

Revenue Forecast, Competitive Landscape, Growth Factors, and Trends

Geographies Covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Countries Covered

U.S., Canada, Germany, U.K., France, Spain, Italy, Rest of Europe, Japan, China, India, Australia & New Zealand, South Korea, Rest of Asia Pacific, Brazil, Mexico, Rest of Latin America, GCC, South Africa, Rest of Middle East & Africa

Key Companies Profiled

Sanofi, Astellas Pharma US, Inc., Myovant Sciences Ltd., Ipsen Pharma, AbbVie Inc., Johnson & Johnson Services, Inc., BG Bayer, AstraZeneca, Tolmar Pharmaceuticals Inc., Ferring B.V, Takeda Pharmaceutical company, Teva Pharmaceutical Industries Ltd., Dendreon Pharmaceuticals LLC, Pfizer Inc., Abbott, GlaxoSmithKline plc, Bristol-Myers Squibb Company, Hoffmann-La Roche Ltd, Novartis AG, Genentech, Inc

Key Questions Answered in Prostate Cancer Therapeutics Market Report

Sanofi, Astellas Pharma US, Inc., Myovant Sciences Ltd., Ipsen Pharma, AbbVie Inc., Johnson & Johnson Services, Inc., BG Bayer, AstraZeneca, etc.

Trends:  rising management of self-care chronic diseases, initiatives taken by the government, etc., Drivers: Growing prostate cancer population, increasing public awareness about prostate cancer therapy, greater R &D investment by drug developers, etc., Opportunities: Growing preference for biosimilar drugs, support from government & insurance providers, etc., challenges: Failure to provide drug and treatment on time, High cost of targeted therapies,  and immunotherapies, low awareness of technological advancement among people, etc.

North America

Hormonal Therapy (Therapy Segmentation)

Development of new products& their introduction, approval, agreement, collaborations, and mergers., etc.

Single User - $4,600.00

It allows one person, the buyer, to have the sole rights and access to the purchased report. Further distribution of the product is strictly prohibited.

It allows the purchased product to be shared among 1-7 employees of your organization within the same geographical location.

It allows the purchased product to be shared among all employees of your organization irrespective of their geographical location.

Need a Custom Report?

We can customize every report – free of charge – including purchasing stand-alone sections or country-level reports

Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

Business Development

small c popup.png
Complete the form below and we'll get back to you shortly
small c popup.png
Complete the form below and we'll get back to you shortly
small c popup.png
Complete the form below and we'll get back to you shortly
Ask an Expert